Global Markets
Home›Global Markets›North America›Lords Mark Industries shares rise after UK IVD portfol…
Lords Mark Industries shares rise after UK IVD portfolio registration
The company said its IVD portfolio registration with the UK’s MHRA follows earlier MHRA approval for an AI-powered haemodialysis system in September, supporting its UK and UK-allied rollout.
Lords Mark Industries Limited shares jumped after the company said it registered an in vitro diagnostics, or IVD, portfolio with the UK’s Medicines and Healthcare products Regulatory Agency, MHRA.
According to LiveMint Markets, the company achieved the milestone shortly after entering the UK and UK-allied markets, with the stock ending Monday nearly 2.57% higher after surging more than 4% during the session and moving close to its upper circuit level.
LiveMint Markets reported that the registration is expected to strengthen the company’s plans to expand its healthcare and diagnostics presence in the UK and UK-allied markets, and it extends its international roadmap beyond renal-care technology to diagnostics.
The update also comes after the company secured MHRA registration for its AI-powered haemodialysis system earlier in September, which enabled its entry into the UK and UK-allied markets.